Back to search
FDAFDA · Food and drugs·Recall number D-0335-2019

infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23, UPC 0 78742 02016 7.

Published December 26, 2018 · Recall initiated: November 26, 2018

Summary

FDA records drug Class II recall D-0335-2019, published December 26, 2018 and initiated November 26, 2018. Recalling firm: Tris Pharma Inc.; Status: Terminated; Reported quantity: 164,304 bottles; Lot: Lot #: 00717009A, Exp 02/19; 00717015A, Exp 04/19; 00717024A, Exp 08/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tris Pharma Inc.
Distributor
One distributor in PA who further distributed Nationwide in the USA.
Lot
Lot #: 00717009A, Exp 02/19; 00717015A, Exp 04/19; 00717024A, Exp 08/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23, UPC 0 78742 02016 7. recalled?

Yes. FDA published recall D-0335-2019 on December 26, 2018. Reported hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

What should I do if I have this product?

Voluntary: Firm initiated · Letter